Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018

Overview of attention for article published in Pharmacology Research & Perspectives, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 11 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 11,676 followers.

RT @MultispanGPCR: One step closer to the development of neutral antagonists of CB1 cannabinoid receptor as research tools and therapeutic…

One step closer to the development of neutral antagonists of CB1 cannabinoid receptor as research tools and therapeutics - the importance of system factors in determining signaling outcomes #GPCR #cannabinoids #neutralantagonist #drugdiscovery #Multisp…

RT @PRandP_Journal: #GPCR neutral antagonists are great research tools when studying receptor activity. However, these compounds are rare!…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.